Lifecore biomedical, inc. receives notice from nasdaq regarding delayed quarterly report

Chaska, minn., april 14, 2023 (globe newswire) -- lifecore biomedical, inc. (nasdaq: lfcr) (the “company”) announced today that it received a notice (“notice”) on april 13, 2023 from the listing qualifications department of the nasdaq stock market (“nasdaq”) stating that the company is not in compliance with nasdaq listing rule 5250(c)(1) (the “listing rule”) because the company failed to timely file its quarterly report on form 10-q for the period ended february 26, 2023 (the “form 10-q”) with the securities and exchange commission.
LFCR Ratings Summary
LFCR Quant Ranking